101
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Correlation Between 25 Hydroxyvitamin D Levels and Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

, ORCID Icon, &
Pages 3099-3107 | Published online: 01 Jul 2021

References

  • Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14(1):32–42. doi:10.1038/nrgastro.2016.147
  • Dai W, Ye L, Liu A, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis. Medicine (Baltimore). 2017;96(39):e8179. doi:10.1097/MD.0000000000008179
  • Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012;56(4):952–964. doi:10.1016/j.jhep.2011.08.025
  • Chacko KR, Reinus J. Extrahepatic complications of nonalcoholic fatty liver disease. Clin Liver Dis. 2016;20(2):387–401. doi:10.1016/j.cld.2015.10.004
  • Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138–1153. doi:10.1136/gutjnl-2017-313884
  • Rathinavelu S, Guidry-Elizondo C, Banu J. Molecular modulation of osteoblasts and osteoclasts in type 2 diabetes. J Diabetes Res. 2018;2018:6354787. doi:10.1155/2018/6354787
  • Leung PS. The potential protective action of vitamin d in hepatic insulin resistance and pancreatic islet dysfunction in type 2 diabetes mellitus. Nutrients. 2016;8(3):147. doi:10.3390/nu8030147
  • Li R, Guo E, Yang J, et al. 1,25(OH)2D3 attenuates hepatic steatosis by inducing autophagy in mice. Obesity (Silver Spring). 2017;25(3):561–571. doi:10.1002/oby.21757
  • Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–854. doi:10.1002/hep.21496
  • Gheorghe G, Bungau S, Ceobanu G, et al. The non-invasive assessment of hepatic fibrosis. J Formos Med Assoc. 2021;120(2):794–803. doi:10.1016/j.jfma.2020.08.019
  • Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6(1):33. doi:10.1186/1471-230X-6-33
  • Chen X, Wang Z, Duan N, Zhu G, Schwarz EM, Xie C. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018;59(2):99–107. doi:10.1080/03008207.2017.1290085
  • Szulc P, Naylor K, Hoyle NR, Eastell R, Leary ET. National bone health alliance bone turnover marker P: use of CTX-I and PINP as bone turnover markers: national bone health alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Osteoporos Int. 2017;28(9):2541–2556. doi:10.1007/s00198-017-4082-4
  • Xiu L, Yao XA, Jiang T. Correlation between 25-hydroxyvitamin d level and cardiac diastolic dysfunction in chinese adults with early-onset type 2 diabetes mellitus: a cross-sectional Study. Diabetes Metab Syndr Obes. 2021;14:1823–1831. doi:10.2147/DMSO.S299422
  • Mayfield J. Diagnosis and classification of diabetes mellitus: new criteria. Am Fam Physician. 1998;58(1355–62):69–70.
  • Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed). 1986;292(6512):13–15. doi:10.1136/bmj.292.6512.13
  • Roth CL, Elfers CT, Figlewicz DP, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology. 2012;55(4):1103–1111. doi:10.1002/hep.24737
  • Nelson JE, Roth CL, Wilson LA, et al. Vitamin D deficiency is associated with increased risk of non-alcoholic steatohepatitis in adults with non-alcoholic fatty liver disease: possible role for MAPK and NF-kappaB? Am J Gastroenterol. 2016;111(6):852–863. doi:10.1038/ajg.2016.51
  • Targher G, Lonardo A, Rossini M. Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link? J Endocrinol Invest. 2015;38(8):817–825. doi:10.1007/s40618-015-0315-6
  • Nakchbandi IA, van der Merwe SW. Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol. 2009;6(11):660–670. doi:10.1038/nrgastro.2009.166
  • Mantovani A, Sani E, Fassio A, et al. Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes. Diabetes Metab. 2019;45(4):347–355. doi:10.1016/j.diabet.2018.10.001
  • Zou W, Hakim I, Tschoep K, Endres S, Bar-Shavit Z. Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J Cell Biochem. 2001;83(1):70–83. doi:10.1002/jcb.1202
  • Nanes MS. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene. 2003;321:1–15. doi:10.1016/S0378-1119(03)00841-2
  • Lee HL, Yi T, Woo KM, Ryoo HM, Kim GS, Baek JH. Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation. Exp Mol Med. 2010;42(6):437–445. doi:10.3858/emm.2010.42.6.045
  • Novince CM, Whittow CR, Aartun JD, et al. Commensal gut microbiota immunomodulatory actions in bone marrow and liver have catabolic effects on skeletal homeostasis in health. Sci Rep. 2017;7(1):5747. doi:10.1038/s41598-017-06126-x
  • Ohlsson C, Mohan S, Sjogren K, et al. The role of liver-derived insulin-like growth factor-I. Endocr Rev. 2009;30:494–535.
  • Zhang Y, Jiang X, Li X, et al. Serum vitamin D levels and risk of liver cancer: a systematic review and dose-response meta-analysis of cohort Studies. Nutr Cancer. 2020;1–9.
  • Alhabeeb H, Kord-Varkaneh H, Tan SC, et al. The influence of omega-3 supplementation on vitamin D levels in humans: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020;1–8.